Home Growth hormone treatment in children with short stature: impact of the diagnosis on parents
Article
Licensed
Unlicensed Requires Authentication

Growth hormone treatment in children with short stature: impact of the diagnosis on parents

  • Stefanie Witt ORCID logo EMAIL logo , Janika Bloemeke , Monika Bullinger ORCID logo , Helmuth-Günther Dörr , Neuza Silva ORCID logo and Julia Hannah Quitmann ORCID logo
Published/Copyright: March 1, 2024

Abstract

Objectives

This prospective multicenter study aimed (1) to examine changes in parent-reported health-related quality of life (HRQOL) of children with short stature and the effects of the children’s condition on parents themselves within the first year of human growth hormone (hGH) treatment and (2) to predict effects on parents based on main and interaction effects of children’s HRQOL and increase in height.

Methods

A total of 110 parents of children aged 4–18 years, diagnosed with idiopathic growth hormone deficiency, small for gestational age, or idiopathic short stature, were recruited from 11 participating German pediatric endocrinologists and asked to fill out the short stature-specific Quality of Life in Short Stature Youth (QoLISSY) Questionnaire before hGH treatment was initiated and one year later.

Results

Negative effects of the children’s short stature on the parents decrease over time, independent of diagnosis and treatment status. Furthermore, treatment status and height increase moderated the links between children’s improved HRQOL as perceived by their parents and decreased caregiving burden.

Conclusions

Based on the children’s improved HRQOL and the parent’s decrease in caregiving burden, patient-reported outcomes that consider parental and child’s perspectives should be considered when deciding on hGH treatment for children.


Corresponding author: Dr. Stefanie Witt, Department of Medical Psychology, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg 20251, Germany, E-mail:
Neuza Silva and Julia Quitmann share last authorship.

Funding source: Pfizer

Acknowledgments

We thank all participating clinicians, namely Ilker Akkurt (Hamburg), Desiree Dunstheimer (Augsburg), Christian Vogel (Chemnitz), Volker Böttcher (Frankfurt/Main), Ursula Kuhnle Krahl (Gauting), Markus Bettendorf (Heidelberg), Eckhard Schönau (Cologne), Susanne Fricke-Otto (Krefeld), Alexandra Keller (Leipzig), Klaus Mohnike (Magdeburg), and Helmuth-Günther Dörr (Erlangen). In particular, we thank all participating families for sharing their experiences with us.

  1. Research ethics: The study was approved by the appropriate Ethics Committees and was conducted following the ethical standard laid down in the 1964 Declaration of Helsinki and its later amendments.

  2. Informed consent: Written informed consent was obtained from all participants and parents (where participants were under 16 years old) before the study. Patients signed informed consent regarding publishing their anonymized data.

  3. Author contributions: Monika Bullinger, Helmuth-Günther Dörr, and Julia Quitmann contributed to the study conception and design. Stefanie Witt, Neuza Silva, Janika Bloemeke and Julia Quitmann performed material preparation, data collection, and analysis. Neuza Silva and Stefanie Witt wrote the manuscript’s first draft, and all authors commented on previous versions. All authors have read, approved, and accepted the responsibility for the entire content of this manuscript and its submission.

  4. Competing interests: Monika Bullinger, Julia Quitmann, and the participating clinicians received research funding for conducting the study. The authors received no financial support for the preparation of the manuscript. QoLISSY is a joint initiative between Pfizer Limited and the University Medical Center Hamburg-Eppendorf. Copyright Pfizer Limited, all rights reserved. The European QoLISSY instrument and comprehensive information of its development and validation process are published in the QoLISSY User’s Manual (The European QoLISSY Group 2011). The Manual is available upon request, including QoLISSY child and observer forms and scoring information (http://www.pfizerpatientreportedoutcomes.com/therapeutic-areas/cv-metabolic/endocrine).

  5. Research funding: Pfizer, Inc. sponsored this study. The funding organization played no role in the study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the report for publication.

  6. Data availability: De-identified data will be made readily available to qualified individuals within the scientific community upon request for research purposes.

References

1. Bettendorf, M, Kiepe, D, Knauer-Fischer, S, Wölfle, J. Kleinwuchs bei Kindern und Jugendlichen – Aktuelle Aspekte zur Diagnostik und Therapie. Bremen: UNI-MED Verlag AG; 2009.Search in Google Scholar

2. Pearce, MS, Deary, IJ, Young, AH, Parker, L. Growth in early life and childhood IQ at age 11 years: the Newcastle Thousand families study. Int J Endocrinol 2005;34:673–7. https://doi.org/10.1093/ije/dyi038.Search in Google Scholar PubMed

3. Porter, WT. The physical basis of precocity and dullness. 1893. Nutrition 1992;8:285–97.Search in Google Scholar

4. Stulp, G, Buunk, AP, Verhulst, S, Pollet, TV. Human height is positively related to interpersonal dominance in dyadic interactions. PLoS One 2015;10:e0117860. https://doi.org/10.1371/journal.pone.0117860.Search in Google Scholar PubMed PubMed Central

5. Sudfeld, CR, McCoy, DC, Danaei, G, Fink, G, Ezzati, M, Andrews, KG, et al.. Linear growth and child development in low- and middle-income countries: a meta-analysis. Paediatrics 2015;135:e1266–75. https://doi.org/10.1542/peds.2014-3111.Search in Google Scholar PubMed

6. Tran, TD, Holton, S, Nguyen, H, Fisher, J. Physical growth: is it a good indicator of development in early childhood in low- and middle-income countries? BMC Pediatr 2019;19:276. https://doi.org/10.1186/s12887-019-1654-9.Search in Google Scholar PubMed PubMed Central

7. Binder, G. Kleinwuchs und Therapie. Monatsschr Kinderh 2014;162:299–308. https://doi.org/10.1007/s00112-013-3044-y.Search in Google Scholar

8. Oostdijk, W, Grote, FK, de Muinck Keizer-Schrama, SM, Wit, JM. Diagnostic approach in children with short stature. Horm Res 2009;72:206–17. https://doi.org/10.1159/000236082.Search in Google Scholar PubMed

9. Wit, JM. International classification of pediatric endocrine diagnoses. Horm Res Paediatr 2016;86:212–4. https://doi.org/10.1159/000448893.Search in Google Scholar PubMed PubMed Central

10. Ranke, MB, Lindberg, A, Tanaka, T, Camacho-Hübner, C, Dunger, DB, Geffner, ME. Baseline characteristics and gender differences in Prepubertal children treated with growth hormone in Europe, USA, and Japan: 25 years’ KIGS® experience (1987-2012) and review. Horm Res Paediatr 2017;87:30–41. https://doi.org/10.1159/000452887.Search in Google Scholar PubMed

11. Wit, JM, Reiter, EO, Ross, JL, Saenger, PH, Savage, MO, Rogol, AD, et al.. Idiopathic short stature: management and growth hormone treatment. Growth Horm IGF Res 2008;18:111–35. https://doi.org/10.1016/j.ghir.2007.11.003.Search in Google Scholar PubMed

12. Food and drug administration (FDA). FDA approves humatrope for short stature. Fed Regist 2003;68:24003.Search in Google Scholar

13. Alsaigh, R, Coyne, I. Mothers’ experiences of caring for children receiving growth hormone treatment. J Pediatr Nurs 2019;49:e63–73. https://doi.org/10.1016/j.pedn.2019.09.005.Search in Google Scholar PubMed

14. Majewska, KA, Stanisławska-Kubiak, M, Wiecheć, K, Naskręcka, M, Kędzia, A, Mojs, E. Maternal anxiety in relation to growth failure and growth hormone treatment in children. Medicine 2020;99:e22147. https://doi.org/10.1097/md.0000000000022147.Search in Google Scholar PubMed PubMed Central

15. Silva, N, Bullinger, M, Sommer, R, Rohenkohl, A, Witt, S, Quitmann, J. Children’s psychosocial functioning and parents’ quality of life in paediatric short stature: the mediating role of caregiving stress. Clin Psychol Psychother 2018;25:e107–8. https://doi.org/10.1002/cpp.2146.Search in Google Scholar PubMed

16. van Dongen, N, Kaptein, AA. Parents’ views on growth hormone treatment for their children: psychosocial issues. Patient Prefer Adherence 2012;6:547–53. https://doi.org/10.2147/ppa.s33157.Search in Google Scholar PubMed PubMed Central

17. Rani, D, Shrestha, R, Kanchan, T, Krishan, K. Short stature. In: StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2020, StatPearls Publishing LLC.; 2020.Search in Google Scholar

18. Gordon, M, Crouthamel, C, Post, EM, Richman, RA. Psychosocial aspects of constitutional short stature: social competence, behavior problems, self-esteem, and family functioning. J Pediatr 1982;101:477–80. https://doi.org/10.1016/s0022-3476(82)80093-0.Search in Google Scholar PubMed

19. Keselman, A, Martínez, A, Pantano, L, Bergadá, C, Heinrich, JJ. Psychosocial outcome in growth hormone deficient patients diagnosed during childhood. J Pediatr Endocrinol Metab 2000;13:409–16. https://doi.org/10.1515/jpem.2000.13.4.409.Search in Google Scholar PubMed

20. Sandberg, DE, Voss, LD. The psychosocial consequences of short stature: a review of the evidence. Best Pract Res Clin Endocrinol Metab 2002;16:449–63. https://doi.org/10.1053/beem.2002.0211.Search in Google Scholar PubMed

21. Bullinger, M, Kołtowska-Häggström, M, Sandberg, D, Chaplin, J, Wollmann, H, Noeker, M, et al.. Health-related quality of life of children and adolescents with growth hormone deficiency or idiopathic short stature – part 2: available results and future directions. Horm Res 2009;72:74–81. https://doi.org/10.1159/000232159.Search in Google Scholar PubMed

22. Quitmann, JH, Bullinger, M, Sommer, R, Rohenkohl, AC, Bernardino Da Silva, NM. Associations between psychological problems and quality of life in pediatric short stature from patients’ and parents’ perspectives. PLoS One [Internet] 2016;11:e0153953. https://doi.org/10.1371/journal.pone.0153953.Search in Google Scholar PubMed PubMed Central

23. Zarit, SH, Todd, PA, Zarit, JM. Subjective burden of husbands and wives as caregivers: a longitudinal study. Gerontol 1986;26:260–6. https://doi.org/10.1093/geront/26.3.260.Search in Google Scholar PubMed

24. Piran, P, Khademi, Z, Tayari, N, Mansouri, N. Caregiving burden of children with chronic diseases. Electron Physician 2017;9:5380–7. https://doi.org/10.19082/5380.Search in Google Scholar PubMed PubMed Central

25. Canning, RD, Harris, ES, Kelleher, KJ. Factors predicting distress among caregivers to children with chronic medical conditions. J Pediatr Psychol 1996;21:735–49. https://doi.org/10.1093/jpepsy/21.5.735.Search in Google Scholar PubMed

26. Raina, P, O’Donnell, M, Rosenbaum, P, Brehaut, J, Walter, SD, Russell, D, et al.. The health and well-being of caregivers of children with cerebral palsy. Pediatrics 2005;115:e626–36. https://doi.org/10.1542/peds.2004-1689.Search in Google Scholar PubMed

27. Valizadeh, L, Joonbakhsh, F, Pashaee, S. Determinants of care giving burden in parents of child with cancer at Tabriz children medical and training center. J Clin Nurs 2014;3:13–20.Search in Google Scholar

28. The European QoLISSY Group. Quality of life in short stature youth. The QoLISSY questionnaire user’s manual. Lengerich: Pabst Science Publishers; 2011.Search in Google Scholar

29. Quitmann, J, Rohenkohl, A, Bullinger, M, Chaplin, JE, Herdman, M, Sanz, D, et al.. Parental perception of health-related quality of life in children and adolescents with short stature: literature review and introduction of the parent-reported QoLISSY instrument. Pediatr Endocrinol Rev 2013;11:147–60.Search in Google Scholar

30. IBM Corp. IBM SPSS statistics for windows, version 20.0. Armonk, NY: IBM Corp; 2011.Search in Google Scholar

31. Nunnally, JC. Psychometric theory. McGraw-Hill series in psychology, 3rd ed., internat. stud. ed., [Nachdr.], In: Bernstein, IH, editor. New York, NY: McGraw Hill Education; 1994.Search in Google Scholar

32. Cohen, J. Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum Associates, Inc.; 1988.Search in Google Scholar

33. MacKinnon, DP, Luecken, LJ. How and for whom? Mediation and moderation in health psychology. Health Psychol 2008;27:S99–100.10.1037/0278-6133.27.2(Suppl.).S99Search in Google Scholar PubMed PubMed Central

34. Dancey, CP, Reidy, J. Statistics without maths for psychology. London: Pearson education; 2007.Search in Google Scholar

35. Aiken, L, West, S. Multiple regression: testing and interpreting interactions. Thousand Oaks, CA: SAGE; 1991.Search in Google Scholar

36. Hayes, AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. New York, NY: The Guilford Press; 2013.Search in Google Scholar

37. Frazier, P, Tix, A, Barron, K. Testing moderator and mediator effects in Counseling psychology research. J Counsel Psychol 2004;51:115–34. https://doi.org/10.1037/0022-0167.51.1.115.Search in Google Scholar

38. Jose, P. ModGraph-I: a programme to compute cell means for the graphical display of moderational analyses: the internet version, Version 3.0. Wellington, New Zealand: Victoria University of Wellington; 2013. Available from: https://psychology.victoria.ac.nz/modgraph/.Search in Google Scholar

39. Holmbeck, GN. Post-hoc probing of significant moderational and mediational effects in studies of pediatric populations. J Pediatr Psychol 2002;27:87–96. https://doi.org/10.1093/jpepsy/27.1.87.Search in Google Scholar PubMed

40. Grimberg, A, Cousounis, P, Cucchiara, AJ, Lipman, TH, Ginsburg, KR. Parental concerns influencing decisions to seek medical care for a child’s short stature. Horm Res Paediatr 2015;84:338–48. https://doi.org/10.1159/000440804.Search in Google Scholar PubMed PubMed Central

41. Hitt, T, Ginsburg, KR, Cousounis, P, Lipman, TH, Cucchiara, AJ, Stallings, VA, et al.. Concerns and expectations of parents seeking subspecialist care for their child’s short stature. Horm Res Paediatr 2019;92:311–8. https://doi.org/10.1159/000506739.Search in Google Scholar PubMed PubMed Central

42. Finkelstein, BS, Imperiale, TF, Speroff, T, Marrero, U, Radcliffe, DJ, Cuttler, L. Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med 2002;156:230–40. https://doi.org/10.1001/archpedi.156.3.230.Search in Google Scholar PubMed

43. Geist, R, Grdisa, V, Otley, A. Psychosocial issues in the child with chronic conditions. Best Pract Res Clin Gastroenterol 2003;17:141–52. https://doi.org/10.1016/s1521-6918(02)00142-7.Search in Google Scholar PubMed

44. Simmons, K, Ortiz, R, Kossowsky, J, Krummenacher, P, Grillon, C, Pine, D, et al.. Pain and placebo in pediatrics: a comprehensive review of laboratory and clinical findings. Pain 2014;155:2229–35. https://doi.org/10.1016/j.pain.2014.08.036.Search in Google Scholar PubMed PubMed Central

45. Stephen, MD, Varni, JW, Limbers, CA, Yafi, M, Heptulla, RA, Renukuntla, VS, et al.. Health-related quality of life and cognitive functioning in pediatric short stature: comparison of growth-hormone-naïve, growth-hormone-treated, and healthy samples. Eur J Pediatr 2011;170:351–8. https://doi.org/10.1007/s00431-010-1299-z.Search in Google Scholar PubMed

46. Quitmann, J, Rohenkohl, A, Sommer, R, Bullinger, M, Silva, N. Explaining parent-child (dis)agreement in generic and short stature-specific health-related quality of life reports: do family and social relationships matter? Health Qual Life Outcomes 2016;14:150. https://doi.org/10.1186/s12955-016-0553-0.Search in Google Scholar PubMed PubMed Central

47. Naiki, Y, Horikawa, R, Tanaka, T,Child Health and Development Network. Assessment of psychosocial status among short-stature children with and without growth hormone therapy and their parents. Clin Pediatr Endocrinol 2013;22:25–32. https://doi.org/10.1297/cpe.22.25.Search in Google Scholar

Received: 2023-09-22
Accepted: 2024-02-05
Published Online: 2024-03-01
Published in Print: 2024-04-25

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. The effect of GnRH analog treatment on BMI in children treated for precocious puberty: a systematic review and meta-analysis
  4. Original Articles
  5. Association of hepatokines with markers of endothelial dysfunction and vascular reactivity in obese adolescents
  6. Evaluation of cardiac electrophysiological features in patients with premature adrenarche
  7. Growth hormone treatment in children with short stature: impact of the diagnosis on parents
  8. Ovarian reserve and fertility parameters in post-pubertal females with congenital adrenal hyperplasia: a case-control study
  9. Early change of retinal nerve fiber layer in children with type 1 diabetes mellitus in northern China
  10. Investigating the connection among thyroid function, sensitivity to thyroid hormones, and metabolic syndrome in euthyroid children and adolescents affected by type 1 diabetes
  11. Surgical treatment of secondary hyperparathyroidism in children with chronic kidney disease. Experience in 19 patients
  12. Short Communication
  13. Decline in case rates of youth onset type 2 diabetes in year three of the COVID-19 pandemic
  14. Letters to the Editor
  15. The effect of phenylketonuria on family quality of life
  16. Struggle for the future health of adolescent patients with phenylketonuria and parents with a sick child due to the economic crisis
  17. Case Reports
  18. A new onset drug induced diabetes mellitus presenting with diabetic ketoacidosis in a child undergoing treatment for B cell acute lymphoblastic leukemia. A case report and review of literature
  19. Late diagnosis of the X-linked MCT8 deficiency (Allan–Herndon–Dudley syndrome) in a teenage girl with primary ovarian insufficiency
  20. An infant developing hypercalcemia and hypophosphatemia due to the use of exclusively almond milk
  21. New data supporting that early diagnosis and treatment are possible and necessary in intracellular cobalamin depletion: the case of transcobalamin II deficiency
Downloaded on 16.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2023-0420/html
Scroll to top button